Your browser doesn't support javascript.
loading
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study.
Ecke, Thorsten H; Meisl, Christina J; Schlomm, Thorsten; Rabien, Anja; Labonté, Flora; Rong, Dezhi; Hofbauer, Sebastian; Friedersdorff, Frank; Sommerfeldt, Lilli; Gagel, Nella; Gössl, Andreas; Barski, Dimitri; Otto, Thomas; Grunewald, Camilla M; Niegisch, Günter; Hennig, Martin J P; Kramer, Mario W; Koch, Stefan; Roggisch, Jenny; Hallmann, Steffen; Weiß, Sarah; Waldner, Michael; Graff, Johannes; Veltrup, Elke; Linden, Friederike; Hake, Roland; Eidt, Sebastian; Wirtz, Ralph M.
Afiliação
  • Ecke TH; Department of Urology, Helios Hospital, Bad Saarow, Germany; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. Electronic address: thorsten.ecke@helios-gesundheit
  • Meisl CJ; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Schlomm T; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Rabien A; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Labonté F; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Rong D; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Hofbauer S; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Friedersdorff F; Department of Urology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Department of Urology, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany.
  • Sommerfeldt L; Department of Urology, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany.
  • Gagel N; Department of Urology, Evangelisches Krankenhaus Königin Elisabeth Herzberge, Berlin, Germany.
  • Gössl A; Department of Urology, Rheinland Klinikum Neuss, Neuss, Germany.
  • Barski D; Department of Urology, Rheinland Klinikum Neuss, Neuss, Germany.
  • Otto T; Department of Urology, Rheinland Klinikum Neuss, Neuss, Germany; University Hospital Essen, Essen, Germany.
  • Grunewald CM; Department of Urology, University Hospital, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
  • Niegisch G; Department of Urology, University Hospital, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
  • Hennig MJP; Department of Urology, University Hospital Lübeck, Lübeck, Germany.
  • Kramer MW; Department of Urology, University Hospital Lübeck, Lübeck, Germany.
  • Koch S; Helios Hospital, Institute of Pathology, Bad Saarow, Germany; Brandenburg Medical School, Brandenburg, Germany.
  • Roggisch J; Helios Hospital, Institute of Pathology, Bad Saarow, Germany.
  • Hallmann S; Department of Urology, Helios Hospital, Bad Saarow, Germany.
  • Weiß S; Department of Urology, Helios Hospital, Bad Saarow, Germany.
  • Waldner M; Department of Urology, St. Elisabeth Hospital, Cologne, Germany.
  • Graff J; Department of Urology, St. Elisabeth Hospital, Cologne, Germany.
  • Veltrup E; STRATIFYER Molecular Pathology GmbH, Cologne, Germany.
  • Linden F; STRATIFYER Molecular Pathology GmbH, Cologne, Germany.
  • Hake R; Institute of Pathology, St. Elisabeth Hospital, Cologne, Germany.
  • Eidt S; Institute of Pathology, St. Elisabeth Hospital, Cologne, Germany.
  • Wirtz RM; STRATIFYER Molecular Pathology GmbH, Cologne, Germany.
Urol Oncol ; 41(12): 484.e17-484.e26, 2023 12.
Article em En | MEDLINE | ID: mdl-37407421
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Biomarcadores Tumorais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Biomarcadores Tumorais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2023 Tipo de documento: Article